Table VI.

The Mean T _50% Values of Drugs Compared with Drug–Ovalbumin–Gelatin Microcapsules

Drug	T 50% (min)		Independent samples t test
	Powder	Microcapsules
PE (A)	5.29 ± 0.27	43.40 ± 1.15	P < 0.001
VP (B)	5.39 ± 0.36	44.01 ± 2.32	P < 0.01
PP (C)	5.36 ± 0.31	44.76 ± 2.01	P < 0.01
PC (D)	6.46 ± 0.22	79.32 ± 14.82	P < 0.05
Statistical analysis
F	10.838	16.204
Significance	P < 0.01	P < 0.01
Tukey’s HSD
D > A, B, and C	P < 0.01	P < 0.01
CU1 (A)	86.90 ± 4.19	231.56 ± 12.45	P < 0.01
CU2 (B)	89.18 ± 1.51	246.45 ± 13.22	P < 0.01
CU3 (C)	92.04 ± 1.47	257.03 ± 15.29	P < 0.01
Statistical analysis
F	2.715	2.615
Significance	P > 0.05	P > 0.05
PC	8.62 ± 0.72	43.64 ± 3.73	P < 0.01
PE	5.11 ± 0.29	42.40 ± 2.72	P < 0.01
Independent samples t test	P < 0.01	P > 0.05

Mean ± SD (N = 3)

CU1 curcumin 1, CU2 curcumin 2, CU3 curcumin 3